Mix-ups and mycoplasma: the enemies within

被引:43
作者
Drexler, HG [1 ]
Uphoff, CC [1 ]
Dirks, WG [1 ]
MacLeod, RAF [1 ]
机构
[1] DSMZ, German Coll Microorgan & Cell Cultures, Dept Human & Anim Cell Cultures, D-38124 Braunschweig, Germany
关键词
cell lines; cross-contamination; leukemia; lymphoma; mycoplasma;
D O I
10.1016/S0145-2126(01)00136-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human leukemia-lymphoma (LL) cell lines represent important tools for experimental research. Among the various problems associated with cell lines. the two most common concern contaminations: (1) cross-contamination with unrelated cells and (2) contamination with microorganisms, in particular mycoplasma. The bad news is that about one-third of the cell lines are either cross-contaminated or mycoplasma-infected or both. The good news is that there are means to recognize and overcome these problems. In cases where, during attempts to establish new LL cell lines, primary LL cultures are cross-contaminated with continuous cell lines. intended new cell lines simply cannot be established ("early" cross-contamination). In cases of "late" cross-contamination of existing LL cell lines where the intrusive cells have a growth advantage, the original ("uncontaminated") cell lines may still be available elsewhere. DNA fingerprinting and cytogenetic analysis appear to be the most suitable approaches to detect cross-contaminations and to authenticate LL cell lines. A different but related aspect of "false" LL cell lines is the frequent misclassification of cell lines whereby the actual cell type of the cell line does not correspond to the purported model character of the cell line. Mycoplasma infection can have a multitude of effects on the eukaryotic cells which, due to the variety of infecting mycoplasma species and many other contributing parameters, cannot be predicted, rendering resulting data questionable at best. Practical procedures for the detection and elimination of mycoplasma contamination have been developed. Diagnostic and preventive strategies in order to hem the alarming increase in "false" and mycoplasma-positive LL cell lines are recommended. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:329 / 333
页数:5
相关论文
共 13 条
[1]  
Drexler H., 2001, DSMZ CATALOGUE HUMAN, Veighth
[2]  
Drexler H. G., 2000, LEUKEMIA LYMPHOMA CE
[3]   Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia [J].
Drexler, HG ;
Matsuo, Y .
LEUKEMIA RESEARCH, 2000, 24 (08) :681-703
[4]   False human hematopoietic cell lines: cross-contaminations and misinterpretations [J].
Drexler, HG ;
Dirks, WG ;
MacLeod, RAF .
LEUKEMIA, 1999, 13 (10) :1601-1607
[5]   Guidelines for the characterization and publication of human malignant hematopoietic cell lines [J].
Drexler, HG ;
Matsuo, Y .
LEUKEMIA, 1999, 13 (06) :835-842
[6]   p53 alterations in human leukemia-lymphoma cell lines:: in vitro artifact or prerequisite for cell immortalization? [J].
Drexler, HG ;
Fombonne, S ;
Matsuo, Y ;
Hu, ZB ;
Hamaguchi, H ;
Uphoff, CC .
LEUKEMIA, 2000, 14 (01) :198-206
[7]   Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells [J].
Drexler, HG .
LEUKEMIA, 1998, 12 (06) :845-859
[8]  
Handin RI, 1997, BLOOD, V89, P4238
[9]   Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting [J].
MacLeod, RAF ;
Dirks, WG ;
Reid, YA ;
Hay, RJ ;
Drexler, HG .
LEUKEMIA, 1997, 11 (12) :2032-2038
[10]  
MacLeod RAF, 1999, INT J CANCER, V83, P555